Schedule 13G ownership disclosure

TRAWS PHARMA INC

Common Stock, par value $.01 per share · CUSIP: 68232V884

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 523,359.00 · Class: 7.4%

  • Squadron Capital Management LLC

    Shares: 591,000.00 · Class: 8.4%

  • Matthew Sesterhenn

    Shares: 591,000.00 · Class: 8.4%

  • William Blank

    Shares: 591,000.00 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-25-000010
Form type
SCHEDULE 13G/A
Filer
Squadron Capital Management LLC
CIK
CIK 2050709
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub